New Treatment Target Identified for Diffuse Large B-Cell Lymphoma



NCI researchers have identified new therapeutic targets for diffuse large B-cell lymphoma. Drugs that hit these targets are under clinical development and the researchers hope to begin testing them in clinical trials of patients with DLBCL.



Source link

Comments are closed.